These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 15464915)
1. Cytokine modulation of the innate immune system in the treatment of leukemia and lymphoma. Farag SS; Caligiuri MA Adv Pharmacol; 2004; 51():295-318. PubMed ID: 15464915 [No Abstract] [Full Text] [Related]
2. [Immunotherapy of hemato-oncologic diseases]. Winkler U; Bohlen H; Schirrmacher V; Schlimok G; Voliotis D; Brach M; Niederle N; Tesch H; Diehl V; Engert A Med Klin (Munich); 1996 Apr; 91(4):226-33. PubMed ID: 8692109 [No Abstract] [Full Text] [Related]
3. Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphoma. Har-Noy M; Zeira M; Weiss L; Fingerut E; Or R; Slavin S Leuk Res; 2009 Apr; 33(4):525-38. PubMed ID: 18834631 [TBL] [Abstract][Full Text] [Related]
4. Somatic cell engineering and the immunotherapy of leukemias and lymphomas. Brentjens RJ; Sadelain M Adv Pharmacol; 2004; 51():347-70. PubMed ID: 15464917 [No Abstract] [Full Text] [Related]
5. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia. Horton HM; Bernett MJ; Pong E; Peipp M; Karki S; Chu SY; Richards JO; Vostiar I; Joyce PF; Repp R; Desjarlais JR; Zhukovsky EA Cancer Res; 2008 Oct; 68(19):8049-57. PubMed ID: 18829563 [TBL] [Abstract][Full Text] [Related]
6. Cytokines in cancer immunity and immunotherapy. Smyth MJ; Cretney E; Kershaw MH; Hayakawa Y Immunol Rev; 2004 Dec; 202():275-93. PubMed ID: 15546400 [TBL] [Abstract][Full Text] [Related]
7. Donor lymphocyte infusions. Ho VT; Alyea EP Adv Pharmacol; 2004; 51():319-45. PubMed ID: 15464916 [No Abstract] [Full Text] [Related]
8. Combinational IL-2/IL-15 induction does not further enhance IL-15-induced lymphokine-activated killer cell cytotoxicity against human leukemia/lymphoma cells. Ozdemir O; Savaşan S Clin Immunol; 2005 Jun; 115(3):240-9. PubMed ID: 15893691 [TBL] [Abstract][Full Text] [Related]
10. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Calcagni E; Elenkov I Ann N Y Acad Sci; 2006 Jun; 1069():62-76. PubMed ID: 16855135 [TBL] [Abstract][Full Text] [Related]
12. Comparison of select innate immune mechanisms of fish and mammals. Plouffe DA; Hanington PC; Walsh JG; Wilson EC; Belosevic M Xenotransplantation; 2005 Jul; 12(4):266-77. PubMed ID: 15943775 [TBL] [Abstract][Full Text] [Related]
15. Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury. Tiegs G Z Gastroenterol; 2007 Jan; 45(1):63-70. PubMed ID: 17236122 [TBL] [Abstract][Full Text] [Related]
16. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors. Khawli LA; Hu P; Epstein AL Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951 [TBL] [Abstract][Full Text] [Related]
17. Immunologic approaches to the classification and management of lymphomas and leukemias. Cancer Treat Res; 1988; 38():1-283. PubMed ID: 2908592 [No Abstract] [Full Text] [Related]
18. Haematological applications of interleukin-2 and other immunostimulatory cytokines. Brenner MK Baillieres Clin Haematol; 1994 Mar; 7(1):115-34. PubMed ID: 7913638 [No Abstract] [Full Text] [Related]
19. The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma. Enblad G; Molin D; Glimelius I; Fischer M; Nilsson G Hematol Oncol Clin North Am; 2007 Oct; 21(5):805-23. PubMed ID: 17908621 [TBL] [Abstract][Full Text] [Related]
20. C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. Fraser DA; Bohlson SS; Jasinskiene N; Rawal N; Palmarini G; Ruiz S; Rochford R; Tenner AJ J Leukoc Biol; 2006 Jul; 80(1):107-16. PubMed ID: 16617157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]